PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsbipolar disorder
MeSH D001714 - bipolar disorder
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D000068105:Bipolar and related disorders
0 Companies
0 Drugs
Success rate
D001714: 
Bipolar disorder
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCarbamazepine Carbamazepine  2012-09-20   
Clozapine Clozapine  1997-11-26   
Carbamazepine Epitol  1986-09-17   
Gabapentin Gabapentin  2004-10-08   
Lamotrigine Lamotrigine  2006-08-30   
Lurasidone Lurasidone  2019-05-17   
Olanzapine Olanzapine  2011-10-24   
Olanzapine, Fluoxetine Olanzapine Fluoxetine  2012-06-19   
Olanzapine Olanzapine Teva  2007-12-12   
Paliperidone Paliperidone  2021-07-06   
Quetiapine Quetiapine  2012-03-27   
Topiramate Topiramate  2009-03-27   
Risperidone Uzedy 2025-01-12 2023-04-28   
Risperidone Risperidone  2023-12-05   
Novast LaboratoriesQuetiapine Quetiapine  2017-11-29   
Carbamazepine Carbamazepine  2022-12-02   
Taro PharmaceuticalCarbamazepine Carbamazepine  1996-10-03   
Gabapentin Gabapentin  2013-07-03   
Lamotrigine Lamotrigine  2009-01-27   
Risperidone Risperidone  2011-02-07   
Carbamazepine Teril  2003-09-26   
Glenmark PharmaceuticalsGabapentin Gabapentin  2006-08-18   
Lamotrigine Lamotrigine  2009-02-19   
Lithium Lithium  2009-02-03   
Olanzapine Olazax  2009-12-11   
Olanzapine Olazax Disperzi  2009-12-10   
Topiramate Topiramate  2009-03-27   
MylanAripiprazole Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen)  2015-06-30   
Clozapine Clozapine  1999-05-27   
Gabapentin Gabapentin  2011-02-14   
Lamotrigine Lamotrigine  2009-01-22   
Lithium Lithium  2002-06-27   
Olanzapine Olanzapine  2014-05-12   
Olanzapine Olanzapine Mylan  2008-10-06   
Quetiapine Quetiapine  2012-03-27   
NATCO PharmaLamotrigine Lamotrigine  2009-01-27   
Olanzapine Olanzapine  2012-04-23   
Topiramate Topiramate  2009-03-27   
Johnson & JohnsonPaliperidone Byannli (previously Paliperidone Janssen-Cilag International)  2020-06-18   
Paliperidone Invega  2006-12-19 $4,222 M Y2024 
Paliperidone Invega Hafyera 2036-04-05 2015-05-18   
Paliperidone Invega Sustenna 2031-01-26 2009-07-31   
Risperidone Risperdal  1993-12-29 $374 M Y2022 
Topiramate Topamax  1996-12-24   
Paliperidone Trevicta (previously Paliperidone Janssen)  2014-12-05   
Paliperidone Xeplion  2011-03-04   
GSKLamotrigine Lamictal  1994-12-27   
CiplaGabapentin Gabapentin  2009-12-30   
Lurasidone Lurasidone  2019-01-03   
Olanzapine Olanzapine Cipla (previously Olanzapine Neopharma)  2007-11-14   
Topiramate Topiramate  2009-03-27   
1
2
3
4
5
6
...
15
>
Clinical Trials
Historical Success Rate
Phase 1
85%
40/47
Phase 2
51%
45/88
Phase 3
69%
65/94
Approved: 24Overall Success rate: 30%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
4
5
6
...
10
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use